Navigation Links
Judge Reserves Judgment In Cancer Drug Case

A High Court judge has revealed that he will not give an immediate judgment with regard to Ann Marie Rogers, a breast cancer patient, concerning her case against the NHS refusing her the Herceptin drug treatment. //Justice Bean has revealed that the case is too important as it will have its impact on other breast cancer patients also, for an immediate judgment. There will be no case of undue delay either, according to him. The Herceptin drug reduces the possibility of the HER-2 form of cancer by 50%.

The Swindon Primary Care Trust (PCT) is reported to have refused the drug to Marie Rogers, and she has been compelled to borrow £5,000 to finance her treatment. She is reported to have come to a stage wherein she can no longer afford the treatment. The PCT is funding the treatment with the drug in early stage cancers only in exceptional cases, which is sought to be declared irrational, arbitrary, and unlawful by Ian Wise, who is representing Ms Rogers.

The annual cost of treating a patient with the Herceptin drug is £21,800. Ms Rogers stands a 57% chance of her ailment recurring after a period of 10 years, according to Ian Wise, and refusing to finance her treatment may result in fatal consequences, thus depriving her of her right to life.

The advocate for the PCT, Philip Havers contends that the drug is yet to be licensed for early stage breast cancer, nor has its safety and efficacy been certified by the National Institute for Clinical Excellence (NICE). The policy of the PCT is also in conformity with the guidance of the Health Secretary, according to him. The judge is seeking to decide if the exceptional circumstances criteria can be made use of in some early stage cancers. A judgment with regard to case is expected to be delivered in the second week of February 2006.
'"/>




Page: 1

Related medicine news :

1. Websites Are Judged In Less Than A Second
2. Patient’s Individual Cardiologist Best Judge For Deciding Appropriate Treatment In Chronic Coronary Artery Diseas
3. Judge bans veiled lawyers in courtrooms
4. Pigeon Feathers to Judge Pollution Levels
5. Marine Reserves Protect Coral Reefs
6. Hospital asked to Compensate Victim – Judgment by Delhi High Cour
7. Judgment In Favor Of Merck For Vioxx Drug
8. Life Or Death: Parents Await High Court Judgment
9. Italian Court Presides Over the Judgment of Incurably Ill Italian Man, Pleading Euthanasia
10. Fibroids unlikely to Turn Cancerous
11. Virus Level could Predict Cervical Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... , ... August 23, 2017 , ... Drs. Steven White ... in Cornelius, NC. By taking advantage of this offer, valued at more than ... regular six-month hygiene cleaning from the dentist, patients receive a complimentary professional whitening procedure. ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... to prove the safety and efficacy of HBOT in treating and helping to ... US, points to research showing the similarities of the wounds to the brain ...
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... The Stevie® Awards have announced the winners ... Awards , the world’s premier business awards competition. , Nominees in the 2017 IBAs were ... by a points system based on the total number of awards won in the IBAs ...
(Date:8/23/2017)... ... August 23, 2017 , ... PreCheck, Inc., a ... 2017 Inc. 5000 with a three-year sales growth of 49 percent . The ... comprises the most comprehensive look at America’s independent entrepreneurs. This represents PreCheck’s fifth ...
(Date:8/23/2017)... ... August 23, 2017 , ... Arizona Spine ... nationally that earned the designation of High Performing Hospitals by U.S. News & World ... indicates a hospital was significantly better than the national average in a given ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... that its Board of Directors has approved the payment of ... of 2017. The cash ... about October 27, 2017 to stockholders of record as of ... of dividends are subject to approval of the Board of ...
(Date:8/7/2017)... Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, announced ... comparisons, unless otherwise noted, are to the quarter ended June ... Quarter 2017 Highlights include: Revenue of ... Total prescriptions dispensed of 220,000, compared to ... Gross profit per prescription dispensed of ...
(Date:8/4/2017)... -- The search for test results that can be ... long been the goal of healthcare providers and the ... largest meeting of lab professionals and IVD firms this ... Kalorama Information.  The firm said scores of companies with ... and software were at the American Association for Clinical ...
Breaking Medicine Technology: